APC and intestinal disorder: While endoscopic evaluation of the regression of individual Apc-mutant mouse colon polyps following RAP dosing has been described [15], [16], the studies in this paper are to the best of our knowledge the first to show dramatic prevention of polyposis formation and/or progression in an Apc mutation-dependent colonic polyposis model.